JPS6016424B2 - carbostyril derivatives - Google Patents
carbostyril derivativesInfo
- Publication number
- JPS6016424B2 JPS6016424B2 JP52025183A JP2518377A JPS6016424B2 JP S6016424 B2 JPS6016424 B2 JP S6016424B2 JP 52025183 A JP52025183 A JP 52025183A JP 2518377 A JP2518377 A JP 2518377A JP S6016424 B2 JPS6016424 B2 JP S6016424B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxypropoxy
- dihydrocarbostyryl
- acid
- compound
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title description 3
- 239000002253 acid Substances 0.000 claims description 6
- 125000005606 carbostyryl group Chemical group 0.000 claims description 4
- 125000005359 phenoxyalkyl group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- -1 2-methyl-2-phenylpropyl Chemical group 0.000 description 29
- 150000001875 compounds Chemical class 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000006309 butyl amino group Chemical group 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- DHHVAGZRUROJKS-UHFFFAOYSA-N Phentermine Natural products CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229940090012 bentyl Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008710 crystal-8 Substances 0.000 description 1
- GUBNMFJOJGDCEL-UHFFFAOYSA-N dicyclomine hydrochloride Chemical group [Cl-].C1CCCCC1C1(C(=O)OCC[NH+](CC)CC)CCCCC1 GUBNMFJOJGDCEL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Description
【発明の詳細な説明】 本発明はカルボスチリル誘導体に関する。[Detailed description of the invention] The present invention relates to carbostyril derivatives.
本発明の化合物は文献末教の新規化合物であり、一般式
〔式中R,は低級アルキル基を、R2はフェニルアルキ
ル基又はフェノキシアルキル基を、カルボスチリル骨格
の3,4位の結合は一重結合又は二重結合を夫々示す。The compound of the present invention is a novel compound disclosed in the literature, and has the general formula: Indicates a bond or a double bond, respectively.
〕で表わされるカルボスチリル誘導体及びその酸付加塩
である。該化合物は8ーアドレナリン作働阻害作用を有
し、8一受容体に選択的に作用する8ーフロッカ−剤と
して極めて有用である他、不整脈、狭心症等の心臓病薬
、抗高血圧薬等としても有用である。上記一股式(1)
においてR,で示される低級アルキル基としては炭素数
1〜6の直鎖若しくは分枝状のアルキル基を挙げること
ができ、具体的にはメチル、エチル、プロピル、イソプ
ロピル、ブチル、ten−ブチル、ベンチル、ヘキシル
基等を例示できる。] and its acid addition salts. This compound has an inhibitory effect on 8-adrenergic function and is extremely useful as an 8-flocker agent that selectively acts on 8-receptors, as well as a drug for heart diseases such as arrhythmia and angina pectoris, and an antihypertensive drug. It is also useful as The above single-pronged type (1)
Examples of the lower alkyl group represented by R include straight-chain or branched alkyl groups having 1 to 6 carbon atoms, specifically methyl, ethyl, propyl, isopropyl, butyl, ten-butyl, Examples include bentyl and hexyl groups.
R2で示されるフェノキシアルキル基としては炭素数1
〜6の直鏡若しくは分枝状のアルキレン基とフェニル基
とが結合した基を挙げることができ、具体的にはペンジ
ル、2−フェニルエチル、1−フエニルエチル、2ーメ
チルー2ーフエニルプロピル、4ーフエニルブチル、6
ーフエニルヘキシル、1,1ージメチルー2ーフエニル
エチル、2ーメチル−4ーフエニルブチル、2ーメチル
ー3−フェニルプロピル基等を例示できる。またフェノ
キシアルキル基としては炭素数1〜6の直鎖若しくは分
枝状のアルキレン基とフェノキシ基とが結合した基を挙
げることができ、具体的にはフヱノキシメチル、2ーフ
ェノキシエチル、1−フエノキシエチル、2ーメチルー
2−フエキシプロピル、4ーフエノキシプチル、6一ー
フエノキシヘキシル、1,1−ジメチルー2ーフヱノキ
シエチル、2ーメチル−4ーフエノキシブチル、2−メ
チル−3−フェノプロピル基等を例示できる。上記フェ
ニルアルキル基及びフェノキシアルキル基はフェニル環
上に1又は2個の同一又は相異なる置換基を有していて
もよい。斯かる置換基としてはメトキシ、ェトキシ、プ
ロポキシ、ィソプロポキシ基等の低級アルコキシ基、メ
チレンジオキシ、エチレンジオキシ基等のァルキレンジ
オキシ基、塩素原子、臭素原子、ヨード原子、弗素原子
等のハロゲン原子等を例示できる。このようなフェニル
基としては2一(4ーフロロフエニル)エチル、2一(
3,4ージブロモフエニル)エチル、2−(3,4−ジ
メトキシフエニル)エチル、2一(3,4−メチレンジ
オキシフエニル)エチル、3一(3,5ージクロルフエ
ニル)プロピル、2一(2ーイソプロポキシフエニル)
エチル、2−(3,4一ジメトキシフエノキシ)エチル
、2一(3,5−ジメトキシフエノキシ)エチル、2一
(3,4ーヱチレンジオキイフエノキシ)エチル、2−
(4ーフロロフエノキシ)エチル、2一((4−ter
tーブトキシフエノキシ)エチル、3−(3,5ージク
ロルフエノキシ)プロピル、2−(4ーメトキシフエノ
キシ)エチル基等を例示できる。本発明の代表的な化合
物を以下に掲げる。The phenoxyalkyl group represented by R2 has 1 carbon number
Examples include groups in which a straight mirror or branched alkylene group and a phenyl group are bonded to each other, and specific examples include penzyl, 2-phenylethyl, 1-phenylethyl, 2-methyl-2-phenylpropyl, and 4-6. -Phenylbutyl, 6
-phenylhexyl, 1,1-dimethyl-2-phenylethyl, 2-methyl-4-phenylbutyl, 2-methyl-3-phenylpropyl and the like. Examples of the phenoxyalkyl group include groups in which a linear or branched alkylene group having 1 to 6 carbon atoms and a phenoxy group are bonded, and specifically, phenoxymethyl, 2-phenoxyethyl, 1-phenoxyethyl, 2-methyl-2-phenoxypropyl, 4-phenoxybutyl, 6-phenoxyhexyl, 1,1-dimethyl-2-phenoxyethyl, 2-methyl-4-phenoxybutyl, 2-methyl- Examples include 3-phenopropyl group. The above phenylalkyl group and phenoxyalkyl group may have one or two identical or different substituents on the phenyl ring. Examples of such substituents include lower alkoxy groups such as methoxy, ethoxy, propoxy, and isopropoxy groups, alkylene dioxy groups such as methylenedioxy and ethylenedioxy groups, and halogen atoms such as chlorine, bromine, iodine, and fluorine atoms. Examples include atoms. Such phenyl groups include 2-(4-fluorophenyl)ethyl, 2-(
3,4-dibromophenyl)ethyl, 2-(3,4-dimethoxyphenyl)ethyl, 2-(3,4-methylenedioxyphenyl)ethyl, 3-(3,5-dichlorophenyl)propyl , 2-(2-isopropoxyphenyl)
Ethyl, 2-(3,4-dimethoxyphenoxy)ethyl, 2-(3,5-dimethoxyphenoxy)ethyl, 2-(3,4-ethylenedioxyphenoxy)ethyl, 2-
(4-fluorophenoxy)ethyl, 2-((4-ter
Examples include t-butoxyphenoxy)ethyl, 3-(3,5-dichlorophenoxy)propyl, and 2-(4-methoxyphenoxy)ethyl groups. Representative compounds of the present invention are listed below.
0 8−メトキシ−5−〔3一(3,4ージメトキシフ
エネチルアミノ)−2−ヒド。0 8-methoxy-5-[3-(3,4-dimethoxyphenethylamino)-2-hydro.
キシプロポキシ〕−3,4ージヒドロカルボスチリルo
8ーエトキシ−5一(3−フエネチルアミ/一2一ヒ
ドロキシプロポキシ)3,4ージヒドロカルボスチリル
o 8−メトキシー5一〔3−(1,1−ジメチル−2
ーフエニルヱチルアミ/)一2−ヒド。xypropoxy]-3,4-dihydrocarbostyryl o
8-ethoxy-5-(3-phenethylami/12-hydroxypropoxy) 3,4-dihydrocarbostyryl o 8-methoxy5-[3-(1,1-dimethyl-2
-phenylethylamine/)-2-hydro.
キシプロボキシ〕一3,4−ジヒドロカルボスチリルo
8ープロポキシ−5一〔3一(6ーフエニルヘキシル
アミノ)一2ーヒドロキシプロポキシ〕一3,4ージヒ
ドロカルボスチリルo 8ーイソプロポキシ−5一〔3
一(2−メチル−2ーフエニルプロピルアミノ)一2一
ヒドロキシプロポキシ〕−3,4−ジヒドロカルボスチ
リルo 8ープロポキシー5一〔3一(3,4ージメト
キシフエネチルアミノ)−2一ヒドロキシプロポキシ〕
一3,4ージヒドロカルボスチリルo 8ーブトキシー
5一〔3−(3,4−ジメトキシフエネチルアミノ)一
2ーヒドのキシプロポキシ〕−3,4−ジヒドロカルボ
スチリルo 8−teれ−ブトキシー5−〔3一(3,
4−ジメトキシフヱネチルアミノ)一2−ヒドロキシプ
ロポキシ〕−3,4ージヒド0力ルボスチリル0 8ー
ヘキシルオキシ−5−〔3−(3,4−ジメトキシフエ
ネチルアミノ)−2−ヒドロキシプロポキシ〕一3,4
ージヒドロカルボスチリルo 8ーブトキシ−5一〔3
一(1,1ージメチル−2一フエニルエチルアミノ)−
2一ヒドロキシプロポキシ〕一3,4−ジヒドロカルボ
スチリルo 8ープトキシー5一〔3一(3,4ージメ
トキシフエネチルアミノ)−2−ヒドロキシプロポキシ
〕力ルボスチリルo 8−メトキシ−5一〔3一(3,
4−ジメトキシフエネチルアミノ)−2−ヒドロキシプ
ロポキシ〕力ルポスチリルo 8ーブトキシ−5一〔3
一(1,1−ジメチル−2一フヱニルエチルアミノ)一
2−ヒドロキシプロポキシ〕カルボスチリルo 8−t
en−ブトキシー5−〔3−(3,4−ジメトキシフエ
ネチルアミノノ)−2一ヒドロキシプロポキシ〕カルポ
スチリルo 8ープロポキシ−5−〔3−(3,4ーメ
チレンジオキシフエネチルアミノ)一2一ヒドロキシプ
ロポキシ〕3,4−ジヒドロカルボスチリルo 8−ブ
トキシー5一{3−〔4−(3,4ージメトキシフエニ
ル)ブチルアミノ〕−2一ヒドロキシプロポキシ}一3
,4−ジヒドロカルボスチリルo 8ープロポキシー5
−{3−〔3一(3,4ージメトキシフエル)ブチルア
ミノ〕−2一ヒドロキシプロポキシ}一3,4ージヒド
ロカルボスチリルo 8−ブトキシー5−〔3一(4ー
クロルフエネチルアミノ)−2一ヒドロキシプロポキシ
〕一3,4ージヒドロカルボスチリルo 8−エトキシ
ー5−〔3一(3,4ージクロルフエネチルアミノ)−
2一ヒドロキシプロポキシ〕一3,4−ジヒドロカルボ
スチリルo 8−プロポキシー5−〔3一(3,4ーメ
チレンジオキシフエネチルアミノ)一2一ヒドロキシプ
ロポキシ〕カルボスチリルo 8ープトキシ−5一(3
一(4ークロルフエネチルアミノ)−2−ヒドロキシプ
ロポキシ〕力ルボスチリルo 8−ブトキシー5一{3
一〔2一(4ーメトキシフエノキシ)エチルアミノ〕−
2−ヒドロキシプロポキシ}一3,4ージヒドロカルボ
スチリルo 8ープロポキシ−5−{3−〔2一(3,
4一ジメトキシフエノキシ)エチルアミノ〕一2−ヒド
ロキシプロポキシ}一3,4ージヒドロカルボスチリル
0 8ーエトキシー5一(3ーフエノキシメチルアミノ
ー2一ヒドロキシプロポキシ)一3,4ージヒドロカル
ボスチリルo 8−ブトキシー5一{3一〔2−(1,
1−ジメチル−2ーフエノキシ)エチルアミノ〕一2一
ヒドロキシプロポキシ}一3,4ージヒドロカルボスチ
リル0 8ーエトキシー5一〔3一(6−フヱノキシキ
シルアミノ)一2一ヒドロキシプロポキシ〕−3,4−
ジヒドロカルボスチリルo 8ーブトキシー{3−〔2
一(4ークロルフエノキシ)エチルアミノ〕一2一ヒド
ロキシプロポキシ}一3,4ージヒドロカルボスチリル
o 8−プロポキシ−{3一〔2一(3,4ーメチレン
ジオキシフエノキシ)エチルアミノ〕−2一ヒドロキシ
プロポキシ}一3,4ージヒドロカルボスチリルo 8
−ブトキシ−{3−2−(4ーメトキシフエノキシ)エ
チルアミノ〕−2一ヒドロキシプロポキシ〕力ルボスチ
リルo 8ープロポキシー5一{3−〔2−(3,4一
ジメトキシフエノキシ)エチルアミノ〕一2−ヒドロキ
シブロポキシ}カルボスチリルo 8ープロポキシー5
一{3−(3,4−ジメトキシフエノキシ)ブチルアミ
ノ〕−2一ヒドロキシプロポキシ}−3,4−ジヒドロ
カルポスチリルo 8−ブトキシー{3−〔2−(4−
クロルフエノキシ)エチルアミノ〕−2一ヒドロキシプ
ロポキシ〕力ルポスチリルo 8−エトキシ−5一(3
ーフエネチルアミノー2−ヒドロキシプロポキシ.)カ
ルボスチリ′レ本発明の化合物は種々の方法により合成
されるが、その一例を挙げれば例えば公知の一般式〔式
中Yは又は
(Xはハロゲン原子)を示す。xyproboxy]-3,4-dihydrocarbostyryl o
8-propoxy-5-[3-(6-phenylhexylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyryl o 8-isopropoxy-5-[3
1(2-Methyl-2-phenylpropylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyryl o 8-propoxy5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxy Propoxy]
-3,4-dihydrocarbostyryl o 8-butoxy 5-[3-(3,4-dimethoxyphenethylamino)-12-hyde xypropoxy]-3,4-dihydrocarbostyryl o 8-te-butoxy 5 - [31 (3,
4-Dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydro Rubostyryl 8-hexyloxy-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-1 3,4
-dihydrocarbostyryl o 8-butoxy-5-[3
-(1,1-dimethyl-2-phenylethylamino)-
2-hydroxypropoxy]-3,4-dihydrocarbostyryl o 8-poxy5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-rubostyryl o 8-methoxy-5-[3- (3,
4-dimethoxyphenethylamino)-2-hydroxypropoxy] 8-butoxy-5-[3
-(1,1-dimethyl-2-phenylethylamino)-2-hydroxypropoxy]carbostyryl o 8-t
en-butoxy5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]carpostyryl o 8-propoxy-5-[3-(3,4-methylenedioxyphenethylamino)-1 2-hydroxypropoxy]3,4-dihydrocarbostyryl o 8-butoxy5-{3-[4-(3,4-dimethoxyphenyl)butylamino]-2-hydroxypropoxy}-3
,4-dihydrocarbostyryl o 8-propoxy 5
-{3-[3-(3,4-dimethoxyfer)butylamino]-2-hydroxypropoxy}-3,4-dihydrocarbostyryl o 8-butoxy5-[3-(4-chlorophenethylamino) -2-hydroxypropoxy]-3,4-dihydrocarbostyryl o 8-ethoxy5-[3-(3,4-dichlorophenethylamino)-
2-hydroxypropoxy]-3,4-dihydrocarbostyryl o 8-propoxy-5-[3-(3,4-methylenedioxyphenethylamino)-22-hydroxypropoxy]carbostyryl o 8-poxy-5-( 3
-(4-Chlorphenethylamino)-2-hydroxypropoxy] Rubostyril o 8-Butoxy5-{3
-[2-(4-methoxyphenoxy)ethylamino]-
2-hydroxypropoxy}-3,4-dihydrocarbostyryl o 8-propoxy-5-{3-[2-(3,
4-dimethoxyphenoxy)ethylamino]-2-hydroxypropoxy}-3,4-dihydrocarbostyryl0 8-ethoxy5-(3-phenoxymethylamino-2-hydroxypropoxy)-3,4-dihydrocarbo styryl o 8-butoxy5-{3-[2-(1,
1-dimethyl-2-phenoxylamino)ethylamino]-121-hydroxypropoxy}-3,4-dihydrocarbostyryl0 8-ethoxy5-[3-(6-phenoxyxylamino)-121-hydroxypropoxy]-3 ,4-
Dihydrocarbostyryl o 8-butoxy {3-[2
1(4-chlorophenoxy)ethylamino]121hydroxypropoxy}13,4-dihydrocarbostyryl o 8-propoxy-{31[21(3,4-methylenedioxyphenoxy)ethyl Amino]-2-hydroxypropoxy}-3,4-dihydrocarbostyryl o 8
-Butoxy-{3-2-(4-methoxyphenoxy)ethylamino]-2-hydroxypropoxy]rubostyril o 8-propoxy-5-{3-[2-(3,4-dimethoxyphenoxy)ethylamino) [1-2-hydroxybropoxy]carbostyryl o 8-propoxy 5
-{3-(3,4-dimethoxyphenoxy)butylamino]-2-hydroxypropoxy}-3,4-dihydrocarpostyryl o 8-butoxy{3-[2-(4-
Chlorphenoxy)ethylamino]-2-hydroxypropoxy]ropostyryl o 8-ethoxy-5-(3
-phenethylamino-2-hydroxypropoxy. ) The compound of the present invention can be synthesized by various methods, one example being a known general formula [wherein Y represents or (X is a halogen atom)].
R,及び3,4位の結合は上記に同じ。R, and the bonds at the 3rd and 4th positions are the same as above.
〕で表わされるカルボスチリル誘導体と一般式
R2NQ (m)
〔式中R2は上記に同じ)で表わされるアミンとを反応
させることにより製造される。] and an amine represented by the general formula R2NQ (m) [wherein R2 is the same as above].
一般式(0)の化合物Yは
であ
る化合物(ェポキシカルボスチリル議導体)と一般式(
m)の化合物との反応は無溶媒でも行なわれるが、例え
ばジオキサン、テトラヒドロフラン等のエーテル類、ベ
ンゼン、トルェン、キシレン等の芳香族炭化水素額のほ
か、水、ジメチルホルムアミド等さらに好ましくはメタ
ノール、エタノール、ィソプロパノール等の極性溶媒中
で行なうのが好ましい。Compound Y of general formula (0) is a compound (epoxycarbostyryl conductor) and general formula (
The reaction with the compound m) can be carried out without a solvent, but for example, in addition to ethers such as dioxane and tetrahydrofuran, aromatic hydrocarbons such as benzene, toluene, and xylene, water, dimethylformamide, and more preferably methanol and ethanol. The reaction is preferably carried out in a polar solvent such as , isopropanol or the like.
式(m)の化合物の使用量は特に限定されず広い範囲か
ら適宜選択され得るが、ェポキシカルボスチリル誘導体
に対して通常等モル〜過剰量、好ましくは3〜8倍モル
量用いるのがよい。該反応は通常〜0〜10000、好
ましくは0〜70qoで行なうのがよい。一般式(0)
の化合物中Yが
であ
る化合物(ハロゲノカルボスチリル議導体)と一般式(
m)の化合物との反応は塩基の存在下若しくは不存在下
にて行なわれる。The amount of the compound of formula (m) to be used is not particularly limited and can be appropriately selected from a wide range, but it is usually used in an equimolar to excess amount, preferably 3 to 8 times the molar amount relative to the epoxycarbostyryl derivative. . The reaction is usually carried out at 0 to 10,000 qo, preferably 0 to 70 qo. General formula (0)
Compounds in which Y is (halogenocarbostyryl derivative) and the general formula (
The reaction with compound m) is carried out in the presence or absence of a base.
斯かる塩基としては水酸化ナトリウム、水酸化カリウム
、炭酸ナトリウム、炭酸カリウム等を例示できる。それ
らのうちで炭酸ナトリウム及び炭酸カリウムを用いるの
が好ましい。該反応は無溶媒で或いはメタノール、エタ
ノール、プロパノール、イソプロパノール等の低級アル
コ−ル額、エーテル、ジオキサン、テトラヒドロフラン
等のエーテル類、ベンゼン、トルェン、キシレン等の芳
香族炭化水素類、水等の溶媒中で行なわれる。メタノー
ル、エタノール、ィソプロパノール等の溶媒中で行なう
のが好ましい。式(血)の化合物の使用量は特に限定さ
れず広い範囲から適宜選択され得るが、ハロゲノカルボ
スチリル誘導体に対して通常過剰量、好ましくは3〜8
倍モル量用いるのがよい。該反応は通常0〜1000○
、好ましくは20〜8ぴ○で行なうのがよい。また上記
ェポキシカルボスチリル誘導体及びハロゲノカルボスチ
リル誘導体の混合物を用いても本発明の化合物を用いる
ことができる。Examples of such bases include sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, and the like. Among them, it is preferable to use sodium carbonate and potassium carbonate. The reaction may be carried out without a solvent or in a solvent such as lower alcohols such as methanol, ethanol, propanol, and isopropanol, ethers such as ether, dioxane, and tetrahydrofuran, aromatic hydrocarbons such as benzene, toluene, and xylene, and water. It will be held in Preferably, the reaction is carried out in a solvent such as methanol, ethanol or isopropanol. The amount of the compound of formula (blood) to be used is not particularly limited and can be appropriately selected from a wide range, but it is usually in excess of the halogenocarbostyryl derivative, preferably 3 to 8
It is better to use twice the molar amount. The reaction is usually 0 to 1000○
, preferably 20 to 8 pi. Furthermore, the compound of the present invention can also be used with a mixture of the above-mentioned epoxycarbostyryl derivatives and halogenocarbostyryl derivatives.
このような混合物を用いるときは、上記と同様の塩基を
用いても用いなくともよく溶媒、式(m)の化合物の量
は上記と同様である。反応温度は0〜100qCで進行
するが、50〜80午0で行なうのがよい。斯かくして
得られる本発明化合物を薬理的に許容される酸と反応さ
せることにより酸付加塩とすることができる。斯かる酸
としては塩化水素、臭化水素、硫酸、硝酸、リン酸、チ
オシアン酸等の無機酸、酢酸、プロピオン酸、シュウ酸
、マレィン酸、、コハク酸、酒石酸、フマール酸、リン
ゴ酸、ェタンスルホン酸、pートルェンスホン酸等の有
機酸を例示できる。本発明の化合物は反応終了後常法に
従って反応混合物から単離される。When such a mixture is used, the same base as above may or may not be used, and the solvent and the amount of the compound of formula (m) are the same as above. The reaction proceeds at a temperature of 0 to 100 qC, preferably 50 to 80 pm. The compound of the present invention thus obtained can be made into an acid addition salt by reacting with a pharmacologically acceptable acid. Such acids include hydrogen chloride, hydrogen bromide, sulfuric acid, nitric acid, phosphoric acid, inorganic acids such as thiocyanic acid, acetic acid, propionic acid, oxalic acid, maleic acid, succinic acid, tartaric acid, fumaric acid, malic acid, and ethane sulfone. Examples include organic acids such as acid and p-toluensulfonic acid. After completion of the reaction, the compound of the present invention is isolated from the reaction mixture according to conventional methods.
例えば分別再結晶法、カラムクロマトグラフィー、薄層
クロマトグラフィー等の慣用手段により精製される。尚
本発明においては一般式(1)のカルボスチリル誘導体
の光学異性体も当然に包含する。For example, it is purified by conventional means such as fractional recrystallization, column chromatography, and thin layer chromatography. Incidentally, the present invention naturally includes optical isomers of the carbostyril derivative of general formula (1).
本発明をより一層明らかにするために製造例を以下に掲
げる。製造例 1
5一(2,3ーエポキシプロポキシ)一8ーメトキシー
3,4ージヒドロカルボスチリル1.0gをメタノール
15の‘に溶解し、2−(3,4ージメトキシフエニル
)エチルアミン1.舷を加えて40〜50℃にて4時間
燈梓する。In order to further clarify the present invention, production examples are listed below. Production Example 1 1.0 g of 5-(2,3-epoxypropoxy)-8-methoxy-3,4-dihydrocarbostyryl was dissolved in 15 parts of methanol, and 2-(3,4-dimethoxyphenyl)ethylamine 1. Add the gunwale and heat for 4 hours at 40-50°C.
反応終了後減圧下に溶媒を留去し残溝ををシリカゲルカ
ラムクロマトで精製する。(シリカゲル:ワコウC−2
00、熔出液:クロロホルム)。その後塩化水素ガス飽
和のエタノールで塩酸塩とし、エタノールを減圧留去す
る。残澄をエタノールから再結晶して無色無定形晶の8
ーメトキシー5一{3−〔2−(3,4−ジメトキシフ
エニル)エチルアミノ〕−2−ヒドロキシプロポキシ}
一3,4−ジヒドロカルボスチリル塩酸塩1.5gを得
る。融点154〜1570製造例2〜8製造例1と同様
にして下記表中の化合物を得る。After the reaction is complete, the solvent is distilled off under reduced pressure and the residue is purified by silica gel column chromatography. (Silica gel: Wako C-2
00, eluate: chloroform). Thereafter, the mixture is converted into a hydrochloride salt with ethanol saturated with hydrogen chloride gas, and the ethanol is distilled off under reduced pressure. Recrystallize the residue from ethanol to obtain colorless amorphous crystal 8.
-Methoxy 5-{3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropoxy}
1.5 g of 3,4-dihydrocarbostyryl hydrochloride is obtained. Melting point: 154-1570 Production Examples 2-8 The compounds shown in the table below were obtained in the same manner as in Production Example 1.
製造例 9
5一(2,3−エポキシプロポキシ)一8ープロポキシ
ー3,4ージヒドロカルポスチリル1.雌をメタノール
15奴に溶解し、2一(3,4ージメトキシフエニル)
エチルアミン1.鬼を加えて、15〜20℃にて12時
間燈梓する。Production Example 9 5-(2,3-epoxypropoxy)-8-propoxy 3,4-dihydrocarpostyryl 1. Dissolve the female in 15 ml of methanol and add 2-(3,4-dimethoxyphenyl)
Ethylamine 1. Add the oni and heat for 12 hours at 15-20℃.
Claims (1)
ルキル基又はフエノキシアルキル基を、カルボスチリル
骨格の3,4位の結合は一重結合又は二重結合を夫々示
す。 〕で表わされるカルボスチリル誘導体及びその酸付加塩
。[Claims] 1 General formula▲ Numerical formula, chemical formula, table, etc.▼ [In the formula, R_1 is a lower alkyl group, R_2 is a phenylalkyl group or a phenoxyalkyl group, The bond at position represents a single bond or a double bond, respectively. ] Carbostyryl derivatives and acid addition salts thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52025183A JPS6016424B2 (en) | 1977-03-07 | 1977-03-07 | carbostyril derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52025183A JPS6016424B2 (en) | 1977-03-07 | 1977-03-07 | carbostyril derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS53111078A JPS53111078A (en) | 1978-09-28 |
| JPS6016424B2 true JPS6016424B2 (en) | 1985-04-25 |
Family
ID=12158870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52025183A Expired JPS6016424B2 (en) | 1977-03-07 | 1977-03-07 | carbostyril derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6016424B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04100802U (en) * | 1991-02-04 | 1992-09-01 | 横山鉄工株式会社 | Sorting device for lumber |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894219A (en) * | 1988-03-29 | 1990-01-16 | University Of Florida | Beta-agonist carbostyril derivatives, assay method and pharmacological composition |
-
1977
- 1977-03-07 JP JP52025183A patent/JPS6016424B2/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04100802U (en) * | 1991-02-04 | 1992-09-01 | 横山鉄工株式会社 | Sorting device for lumber |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53111078A (en) | 1978-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0234872B1 (en) | Carboxamides useful as antiemetic or antipsychotic agents | |
| JPH0123462B2 (en) | ||
| HUT58078A (en) | Process for producing new benzopyran derivatives and pharmaceutical compositions comprising same | |
| JPS5948826B2 (en) | Method for producing 4-phenylpiperidine compound | |
| JPS6160077B2 (en) | ||
| JPS6012350B2 (en) | Method for producing novel arylpiperidine derivatives | |
| JPH0137391B2 (en) | ||
| WO1991005775A1 (en) | Aryl-3 oxazolidinones and their preparation and use | |
| CA2146261A1 (en) | Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds | |
| JPS6330894B2 (en) | ||
| JPH06502635A (en) | biologically active amines | |
| AU761327B2 (en) | Fused benzene heterocycle derivatives and utilization thereof | |
| US4147869A (en) | 3,4-Dihydrocarbostyril derivatives and process for preparing the same | |
| JPS6016424B2 (en) | carbostyril derivatives | |
| JPS6140674B2 (en) | ||
| US4880841A (en) | Process of producing phenethylamine derivatives | |
| US4579861A (en) | Aryloxypropanolamine derivatives, pharmaceutical compositions and adrenegic thereof | |
| US4212808A (en) | 2-Oxiranyl-1,4-benzodioxans | |
| KR840001919B1 (en) | Method for preparing substituted phenoxy-aminopropanol derivatives | |
| EP0009075A1 (en) | Pyridyloxy-propanol amines and esters thereof, process for preparing the same and pharmaceutical compositions containing them | |
| US5198587A (en) | Phenethylamine derivatives | |
| JPH0578554B2 (en) | ||
| EP0105763A1 (en) | Indole compounds, their preparation and pharmaceutical compositions comprising them | |
| JPH0545587B2 (en) | ||
| US4409218A (en) | Analgesic method |